SeqLL IncOTC Pink - Current Information:SEQL
- LAST PRICE1.3000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 1.3000
- Day Range---
- 52 Week Range
- Volume22
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | SEQL |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
SeqLL Inc | 494.8K | -0.1x | --- |
Quantrx Biomedical Corp | 314.8K | -1.2x | --- |
Wellstar International Inc | 8.7K | 0.0x | --- |
OWC Pharmaceutical Research Corp | 500.0 | 0.0x | --- |
Micro Imaging Technology Inc | 2.7K | 0.0x | --- |
ProUroCare Medical Inc | 1.9K | 0.0x | --- |
Company Information
SeqLL Inc. (SeqLL) is a life sciences instrumentation and research services company that is engaged in the development of scientific assets and intellectual property across multiple omics fields. The Company is engaged in the design, development and manufacturing of genetic analysis technologies. It leverages its True Single Molecule Sequencing (tSMS) technology, which enables researchers and clinicians to contribute advancements to scientific research and development. Its tSMS platform offers a single molecule solution for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing by performing detection of nucleic acids without the need for complex sample manipulation. Researchers using its platform can analyze billions of single molecules in a single experiment and generate reproducible data. Its single molecule platform combines a fluorescence-based optical detection apparatus with a precision microfluidics and thermal control system to perform sequencing-by-synthesis.
Contact Information
- Headquarters
- 317 New Boston St Ste 210WOBURN, MA, United States 01801-6231
- Phone
- 781-817-3755
- Fax
- 302-636-5454
Executives
- Chairman of the Board, President, Chief Executive Officer
- Daniel Jones
- Chief Financial Officer, Secretary
- Frances Scally
- Independent Director
- Patrice Milos
- Independent Director
- Douglas Miscoll
- Independent Director
- David Pfeffer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $494.8K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 380.7K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-15.96 |
Book Value | $1.60 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
